Abstract Submission

Abstract submissions for NMS 2010 have now closed.

Authors will receive notification regarding oral/poster session allocation on 31 March, 2010.

Oral

Oral presentations will be allocated 10 minutes in a concurrent seminar session, with 5 minutes for questions.

Posters

Posters should be prepared in portrait format.
Poster display boards have a maximum display area of 2340mm high x 950mm wide.

Any programs and activities described should reflect the principles of quality use of medicines – the primacy of consumers, partnership, consultation, multidisciplinary activity, importance of closing the gap for Aboriginal and Torres Strait Islander people, support for existing activity and systems-based approaches.

Symposium streams:

  1. Medicines in people’s lives
    Abstracts encompassing the aspects of medicines use in the general population and in specific consumer groups are invited to submit in this category. Abstracts on how medicines are used, perceptions and beliefs and the outcomes of medicines use are requested.
  2. Ensuring equity
    Initiatives associated with aspects of medicines and medicines services to be delivered with equity are invited to submit in this category. Issues of geography, social isolation, cultural inequity, and the outcomes of activities to address these issues, for example closing the gap initiatives, are of particular interest.
  3. Creating opportunity
    Opportunities to improve medicines use are generated from top down policy directions and leadership, and from bottom up innovations. Abstracts for initiatives addressing the principles of the National Medicines Policy are requested.
  4. Safe and effective use
    A number of strategies to ensure safe and effective use of medicines are requested; whether they be proactive and preventative health strategies, educational, research or policy innovations to address adverse medicines and promote prevention of recurrence of unsafe or ineffective use. Ideally, abstracts on strategies should encompass both proactive and reactive strategies to promote safe and effective use.
  5. Sustainability
    While a number of initiatives are undertaken to improve the quality use of medicines, ensuring the outcomes of these initiatives in the long term is difficult. Abstracts identifying strategies to translate research into practice, embed new practices into old processes and change management strategies to ensure consumers of medicines achieve optimal medicines use are requested.